DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia
Rau, R. E., Rodriguez, B. A., Luo, M., Jeong, M., Rosen, A., Rogers, J. H., Campbell, C. T., Daigle, S. R., Deng, L., Song, Y., Sweet, S., Chevassut, T., Andreeff, M., Kornblau, S. M., Li, W., GoodellVolume:
128
Language:
english
Journal:
Blood
DOI:
10.1182/blood-2015-11-684225
Date:
August, 2016
File:
PDF, 1.46 MB
english, 2016